e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The coagulation and antifibrynolitic activities are increased in the bronchoalveolar lavage fluid from patients with progressing idiopathic pulmonary fibrosis
J. Chorostowska-Wynimko, A. Rozy, K. Lewandowska, M. Korzeniewska, M. Franczuk, J. Kus, P. Kopinski (Warsaw, Bydgoszcz, Poland)
Source:
Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Session:
Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Session type:
Thematic Poster Session
Number:
3418
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Chorostowska-Wynimko, A. Rozy, K. Lewandowska, M. Korzeniewska, M. Franczuk, J. Kus, P. Kopinski (Warsaw, Bydgoszcz, Poland). The coagulation and antifibrynolitic activities are increased in the bronchoalveolar lavage fluid from patients with progressing idiopathic pulmonary fibrosis. Eur Respir J 2007; 30: Suppl. 51, 3418
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Pulmonary sarcoidosis
Related content which might interest you:
Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
The decrease of surfactant protein D in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005
Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Coagulation activity in bronchoalveolar lavage fluid and blood of interstitial lung diseases patients
Source: Eur Respir J 2003; 22: Suppl. 45, 255s
Year: 2003
Coagulation activity of bronchoalveolar lavage fluid and blood in patients with interstitial lung diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 174s
Year: 2002
Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease
Source: ERJ Open Res, 8 (1) 00481-2021; 10.1183/23120541.00481-2021
Year: 2022
Increased myeloid dendritic cells in the bronchoalveolar lavage fluid of idiopathic pulmonary fibrosis patients
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia
Year: 2020
ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 538s
Year: 2001
Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia
Source: Eur Respir J 2003; 22: 239-244
Year: 2003
Bronchoalveolar lavage in idiopathic pulmonary fibrosis
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Coagulation activity of bronchoalveolar lavage fluid and blood is dependent on pulmonary sarcoidosis stage
Source: Eur Respir J 2003; 22: Suppl. 45, 84s
Year: 2003
High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Increased Clara cell protein 16 levels in the bronchoalveolar lavage fluid of idiopathic pulmonary fibrosis patients
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010
Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Analysis of cellular components of bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis and pulmonary sarcoidosis: focus on lymphocyte and macrophage subpopulations
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept